Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × iberdomide × Clear all

Phase

Phase 2 3 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 3 1

Status

Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 92 Cisplatin 83 Paclitaxel 71 pembrolizumab 56 Cyclophosphamide 47 Gemcitabine 45 Capecitabine 41 Pemetrexed 40 durvalumab 39 Dexamethasone 39 Doxorubicin 38 Radiotherapy 36 Docetaxel 36 Nivolumab 33 Lenalidomide 33 Bevacizumab 32 Oxaliplatin 30 Specimen Handling 29 Rituximab 29 Vincristine 28 Fluorouracil 28 Etoposide 28 Magnetic Resonance Spectroscopy 27 atezolizumab 25 Radiation 24 Prednisone 24 Leucovorin 24 Bortezomib 23 130-nm albumin-bound paclitaxel 20 Letrozole 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04975997 2025-07-10

EXCALIBER-RRMM

Celgene

Phase 3 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡